SUBSCRIBE
SUBSCRIBE

Juno Therapeutics

NEWS
Juno Therapeutics was acquired by Bristol-Myers Squibb in 2019.
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Deals
Juno Therapeutics Files For IPO
November 17, 2014
 · 
1 min read
Price Tag May Be The Challenge For Novartis AG And Juno Therapeutics’ Magical Cancer Drugs
October 8, 2014
 · 
1 min read
Load More
AWARDS
  • NextGen Class of 2015
JOBS
IN THE PRESS
Deals
Celgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
March 6, 2018
 · 
2 min read
Deals
Celgene Announces Expiration of Cash Tender Offer for Shares of Juno Therapeutics, Inc.
March 5, 2018
 · 
3 min read
Deals
Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.
February 2, 2018
 · 
5 min read
Business
Juno Taps Former Genentech Exec as CIO
January 5, 2018
 · 
5 min read
Vyaire Medical Takes Out Revolutionary Medical Dev
Business
Juno, Thermo Fisher Ink CAR T Manufacturing Partnership
December 20, 2017
 · 
4 min read
BioForest
Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH
December 12, 2017
 · 
12 min read
Pharm Country
Juno Therapeutics and Celgene Corporation Release Additional Data From TRANSCEND Trial of JCAR017 in Patients With Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
December 11, 2017
 · 
9 min read
BioForest
Juno Therapeutics Highlights Key Translational Insights With JCAR017 in Patients With DLBCL
December 9, 2017
 · 
6 min read
Business
Juno Therapeutics Signs Licensing Agreements With Lilly, OncoTracker, and Fred Hutchinson Cancer Research Center to Advance Its BCMA-Directed Engineered T Cell Program in Multiple Myeloma With Gamma Secretase Inhibition
December 6, 2017
 · 
6 min read
Business
Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO
November 27, 2017
 · 
7 min read
Load More